NCT06281496

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Rigshospitalet, Denmark · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A developed multimodal intervention targeting late effects in survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) will be evaluated in a two-arm randomized controlled trial with an internal pilot phase.

Detailed description

The study aims to investigate the effect of a stepped care intervention in allo-HSCT survivors on health-related quality of life and late effects. Method: This study is designed as a one-site, two-arm prospective randomized controlled trial proceeding an internal pilot phase. Population/recruitment: Recruitment, inclusion, and exclusion criteria as described in the eligibility section. Included patients will be randomized and allocated 1:1 to an intervention group or a control group. Intervention: a stepped-care multi-modal intervention

Conditions

• Hematological Diseases

Interventions

Type	Name	Description
BEHAVIORAL	AlloCare	Survivorship supportive care

Timeline

• Start date: 2024-11-01
• Primary completion: 2027-10-01
• Completion: 2027-12-01
• First posted: 2024-02-28
• Last updated: 2025-08-01

Locations

1 site across 1 country: Denmark